Evaluation of Amylase Activity in Patients with Type 2 Daibetes Mellitus
American Journal of BioScience
Volume 2, Issue 5, September 2014, Pages: 171-174
Received: Jul. 13, 2014; Accepted: Jul. 31, 2014; Published: Aug. 30, 2014
Views 2698      Downloads 204
Authors
Mufeed Jalil Ewadh, Babylon University, College of Medicine, Biochemistry Dept. Hilla, Iraq
Thana Mohammed Juda, Babylon University, College of Medicine, Biochemistry Dept. Hilla, Iraq
Zinah Abbas Ali, Babylon University, College of Medicine, Biochemistry Dept. Hilla, Iraq
Muna Mufeed Ewadh, Babylon University, College of Medicine, Biochemistry Dept. Hilla, Iraq
Article Tools
Follow on us
Abstract
Diabetes mellitus is a chronic metabolic disorder which is associated with hyperglycemia. It is caused by a derangement in the secretion or function of the endocrinal portion of the pancreas. There is a close anatomical and functional relationship between its exocrine and endocrine portions. The current study was designed to evaluate the changes in amylase levels in diabetic patients and study the correlation of amylase activity with chronic hyperglycemia and duration of diabetes mellitus. The results of study were revealed that amylase activity was low in diabetic patients compared with control and there was negative correlation between amylase activity and hyperglycemia and duration .
Keywords
Amylase Activity, Diabetes Mellitus, Endocrine
To cite this article
Mufeed Jalil Ewadh, Thana Mohammed Juda, Zinah Abbas Ali, Muna Mufeed Ewadh, Evaluation of Amylase Activity in Patients with Type 2 Daibetes Mellitus, American Journal of BioScience. Vol. 2, No. 5, 2014, pp. 171-174. doi: 10.11648/j.ajbio.20140205.11
References
[1]
American Diabetic Association. (2010) Standards of medical care in diabetes-. Diabetes Care,; 33 (Suppl. 1), S11-S61.
[2]
Bechmann L. P,. Hannivoort R. A,. Gerken G,., and. Canbay A . (2012) The interaction of hepatic lipid and glucose metabolism in liver diseases. Journal of Hepatology, ; 56: 4: pp. 952–964
[3]
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus .( 2003) Diabetes Care .,; 26(Supplement 1), S5-16.
[4]
Helaine E., Resnick M . (June 2013) Diabetes Care;36 (6): 1431-1432 .
[5]
Singh J, Yago MD, Adeghate E.( 1999) The role of insulin, glucagon, somatostatin, cholecystokinin, acetylcholine and nerve stimulation in the interactions between the endocrine and exocrine pancreas in normal and diabetic conditions in rats. Int J Diabetes;7(1):114–19.
[6]
Bertelli E, Bendayan M.( 2005) Association between endocrine pancreas and ductal system. More than an epiphenomenon of endocrine differentiation and development. J Histochem Cytochem.;53(9):1071–86.
[7]
Drucker DJ.(2007) The role of gut hormones in glucose homeostasis. J Clin Invest.;117:24–32.
[8]
Barreto SG, Carati CJ, Toouli J, Saccone GT.( 2010)The Islet-acinar Axis of Pancreas: More than Just Insulin. Am J Physiol Gastrointest Liver Physiol.;299:G10–22.
[9]
H.P., H. Zeng, Y. Zhang, R. Jungries and P. Chung et al., (2001) Mol Cell 7(6):1153-63.
[10]
Lernmark, A., (2000). Rapid-onset type 1 diabetes with pancreatic exocrine dysfunction. N. Engl. J. Med., 342: 344-345
[11]
Hayden MR, et al.( 2008):Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultra structural abnormalities. J Cardio metab. Syndr.;3:234–43.
[12]
American Diabetes Association. Diagnosis and classification of diabetes mellitus. (2010)Diabetes Care. 33(Suppl 1):S62–69.
[13]
Swislocki A, Noth R, Hallstone A, Kyger E, Triadafilopoulos G: (2005)Secretin stimulated amylase release into blood is impaired in type 1 diabetes mellitus. Horm Metab Res, 37:326-330.
[14]
Yegneswaran B, Pitchumoni CS (2010)When should serum amylase and lipase levels be repeated in a patient with acute pancreatitis? Cleve Clin J Med, 77:230-231.
[15]
Skrha J, Stĕpán J: (1987)Clinical significance of amylase isoenzyme determination. Acta Univ Carol Med Monogr, 120:1-81.
[16]
Aughsteen AA, Abu-Umair MS, Mahmoud SA.( 2005) Biochemical analysis of serum pancreatic amylase and lipase enzymes in patients with type 1 and type 2 diabetes mellitus. Saudi Med J, 26:73-77.
[17]
Jeong Gyu Leea.( 2011) Sang Wook ParkByung Mann Cho Serum amylase and risk of the metabolic syndrome in Korean adultsClinica Chimica ActaVolume 412, Issues 19–20, 18 September, Pages 1848–1853 .
[18]
American Diabetes Association. (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care,33(Suppl 1):S62-S69.
[19]
Chiolero A, Faeh D, Paccaud F, Cornuz J. (2008) Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr, 87:801–809.
[20]
Lee JG, Park SW, Cho BM, Lee S, Kim YJ, Jeong DW, Yi YH, Cho YH: (2011) Serum amylase and risk of the metabolic syndrome in Korean adults. Clin Chim Acta., 412:1848–1853.
[21]
Nakajima K, Muneyuki T, Munakata H, Kakei M: (2011) Revisiting the cardiometabolic relevance of serum amylase. BMC Res Notes., 4:419.
[22]
Martin SS, Qasim A, Reilly MP: (2008) Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol, 52:1201–1210.
[23]
Gautron L, Elmquist JK.( 2011)Sixteen years and counting: an update on leptin in energy balance. J Clin Invest, 121(6):2087–2093. doi:10.1172/JCI45888.
[24]
Rundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. (2005) American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.Circulation,112:2735-275
[25]
Skrha J, Stĕpán J. (1987) Clinical significance of amylase isoenzyme determination. Acta Univ Carol Med Monogr, 120:1-81.
[26]
Pieper-Bigelow C, Strocchi A, Levitt MD. (1990) Where does serum amylase come from and where does it go? Gastroenterol Clin North Am, 19:793-810.
[27]
Nakajima K, Muneyuki T, Munakata H, Kakei M. (2011) Revisiting the cardiometabolic relevance of serum amylase. BMC Res Notes., 4:419.
[28]
Kahn S., Andrikopoulos S., Verchere C. (1999). Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes.;48:241-25
[29]
SachdevoY. "Clinical Endocrinology and diabetes mellitus(A comprehensive text)., 2008;Vol 2,first ed :908-909.
[30]
Martin SS, Qasim A, Reilly MP. (2008) Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol, 52:1201–1210.
[31]
Toshitaka .,Aksushi A. (2012) latent association of low amylase activity with decrease plasma insulin level .cardiovascdaibetes j .;11 :(80) .
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186